Lange, T.; Ernst, T.; Gruber, F.; Maier, J.; Cross, M.; Müller, M. C.; Niederwieser, D. W.; Hochhaus, A. und Pfirrmann, Markus
(2013):
The quantitative level of T315I mutated BCR-ABL predicts for major molecular response to second line nilotinib or dasatinib treatment in patients with chronic myeloid leukemia.
In: Haematologica, Vol. 98, No. 5: pp. 714-717
| Item Type: | Journal article |
|---|---|
| Faculties: | Medicine > Institute for Medical Information Processing, Biometry and Epidemiology |
| Subjects: | 600 Technology > 610 Medicine and health |
| ISSN: | 1592-8721 |
| Language: | English |
| Item ID: | 32540 |
| Date Deposited: | 15. Feb 2017 14:42 |
| Last Modified: | 04. Nov 2020 13:09 |
Actions (login required)
- View Item
